160. Congenital ichthyosis Clinical trials / Disease details
Clinical trials : 42 / Drugs : 71 - (DrugBank : 21) / Drug target genes : 18 - Drug target pathways : 112
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT02830763 (ClinicalTrials.gov) | September 5, 2016 | 6/7/2016 | Clinical Study on the Safety of CNT-02 for TGCV and NLSD-M | Clinical Study on the Safety and Efficacy of Medium-chain Fatty Acid Capsules (CNT-02) for Primary Triglyceride Deposit Cardiomyovasculopathy (TGCV) and Neutral Lipid Storage Disease With Myopathy (NLSD-M) | Primary Triglyceride Deposit Cardiomyovasculopathy (TGCV);Neutral Lipid Storage Disease With Myopathy (NLSD-M) | Dietary Supplement: CNT-02 | Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan | NULL | Terminated | 20 Years | N/A | All | 2 | N/A | Italy;Japan |